Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bill & Melinda Gates Medical Research Institute
Headquarters: Cambridge, MA, United States of America
Website: http://www.gatesmri.org
Year Founded: N/A
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Mar 15, 2025
Politics, Policy & Law
It’s been a year: BIO CEO Crowley’s plans for Trump 2.0
BIO is engaging Trump to protect and improve FDA, hoping to dodge tariffs, looking for paths to modify IRA and reinstate PRVs
BioCentury | Mar 14, 2025
Management Tracks
Rui Santos Ivo elected as new chair at EMA
Plus: Jane Chung named CEO of Sutro after strategic review, and Richard Law becomes CBO at Haya
BioCentury | Mar 13, 2025
Politics, Policy & Law
Abortion, vaccine politics overshadow votes on heads of FDA, NIH
Senate committee endorsement of Makary at FDA and Bhattacharya at NIH came after resignation of FDA chief counsel, withdrawal of CDC director nominee
BioCentury | Mar 12, 2025
Politics, Policy & Law
House spending bill omits PRV reauthorization, slashes biomedical research program
Fate of continuing resolution in doubt as Senate Democrats balk ahead of Friday deadline to avert government shutdown
BioCentury | Mar 1, 2025
Editor's Commentary
HHS, DOGE make a mockery of transparency, COI pledges — a Perspective
HHS Secretary Kennedy says he won’t consult public on rules, DOGE staff have obvious financial conflicts
BioCentury | Feb 25, 2025
Politics, Policy & Law
Tough path for pill penalty fix
Bipartisan House bill to extend IRA price negotiation window for small molecules to 13 years faces steep future
BioCentury | Feb 21, 2025
Politics, Policy & Law
Trump administration echoes Biden’s defense of IRA drug program
Justice Dept. legal brief comes as industry champions are poised to introduce bipartisan bill to eliminate ‘pill penalty’
BioCentury | Feb 20, 2025
Politics, Policy & Law
CDC vaccine meeting postponement raises red flags
Concerns mount that Trump administration vaccine policies will harm public health, disincentivize vaccine R&D
BioCentury | Feb 14, 2025
Management Tracks
Berns becomes chairman, CEO of Neumora
Plus: Robin Kenselaar named chief commercial officer at Orchard, and an update from Bluejay
BioCentury | Feb 13, 2025
Politics, Policy & Law
House bill looks to revive rare pediatric priority review vouchers
Bipartisan bill would also give FDA power to require trials of pediatric cancer drug combos
Items per page:
1 - 10 of 3176